These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1712644)

  • 1. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow.
    Ashman LK; Cambareri AC; To LB; Levinsky RJ; Juttner CA
    Blood; 1991 Jul; 78(1):30-7. PubMed ID: 1712644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody YB5.B8 identifies the human c-kit protein product.
    Lerner NB; Nocka KH; Cole SR; Qiu FH; Strife A; Ashman LK; Besmer P
    Blood; 1991 May; 77(9):1876-83. PubMed ID: 1708291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
    Ashman LK; Bühring HJ; Aylett GW; Broudy VC; Müller C
    J Cell Physiol; 1994 Mar; 158(3):545-54. PubMed ID: 7510297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilized anti-KIT monoclonal antibody induces ligand-independent dimerization and activation of Steel factor receptor: biologic similarity with membrane-bound form of Steel factor rather than its soluble form.
    Kurosawa K; Miyazawa K; Gotoh A; Katagiri T; Nishimaki J; Ashman LK; Toyama K
    Blood; 1996 Mar; 87(6):2235-43. PubMed ID: 8630383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
    Bühring HJ; Ullrich A; Schaudt K; Müller CA; Busch FW
    Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
    Reisbach G; Bartke I; Kempkes B; Kostka G; Ellwart J; Birner A; Thalmeier K; Mailhammer R; Bornkamm GW; Ullrich A
    Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the anti-c-kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells.
    Okayama Y; Hunt TC; Kassel O; Ashman LK; Church MK
    J Immunol Methods; 1994 Mar; 169(2):153-61. PubMed ID: 7510757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
    Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
    Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells.
    Yamaguchi Y; Gunji Y; Nakamura M; Hayakawa K; Maeda M; Osawa H; Nagayoshi K; Kasahara T; Suda T
    Exp Hematol; 1993 Aug; 21(9):1233-8. PubMed ID: 7687219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile.
    Papayannopoulou T; Brice M; Broudy VC; Zsebo KM
    Blood; 1991 Sep; 78(6):1403-12. PubMed ID: 1715789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes.
    Watt SM; Williamson J; Genevier H; Fawcett J; Simmons DL; Hatzfeld A; Nesbitt SA; Coombe DR
    Blood; 1993 Nov; 82(9):2649-63. PubMed ID: 7693043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
    Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
    Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties.
    Andrews RG; Singer JW; Bernstein ID
    J Exp Med; 1989 May; 169(5):1721-31. PubMed ID: 2469766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure.
    Maciejewski JP; Anderson S; Katevas P; Young NS
    Br J Haematol; 1994 Jun; 87(2):227-34. PubMed ID: 7524621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation.
    Bender JG; Unverzagt K; Walker DE; Lee W; Smith S; Williams S; Van Epps DE
    Clin Immunol Immunopathol; 1994 Jan; 70(1):10-8. PubMed ID: 7505211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
    Sillaber C; Strobl H; Bevec D; Ashman LK; Butterfield JH; Lechner K; Maurer D; Bettelheim P; Valent P
    J Immunol; 1991 Dec; 147(12):4224-8. PubMed ID: 1721642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood.
    Möhle R; Haas R; Hunstein W
    J Hematother; 1993; 2(4):483-9. PubMed ID: 7522108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.